3 Results for "

Hypertensive nephropathy

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Hypertensive nephropathy" in MCE Product Catalog:

Cat. No.: HY-15195
CAS No.: 290815-26-8
Purity:  98.15%
Synonyms: Ro 67-0565; SPP-301
Target:  

Endothelin Receptor

Avosentan (Ro 67-0565; SPP-301) is an orally active endothelin (ETA) receptor antagonist. Avosentan can block the ETA receptor, thereby reducing vascular contraction and exerting a renal protective effect. Avosentan inhibits vascular contraction caused by ET-1 and alleviates the reduction in retinal and optic nerve head blood flow induced by it, lowering intraocular pressure in the glaucoma monkey model. Avosentan non-specifically blocks ETB receptors at high doses, inhibiting ETB-mediated diuresis and natriuresis, and may cause fluid retention. Avosentan can be used to reduce proteinuria with diabetic nephropathy, but induces significant fluid overload and congestive heart failure .
loading...
    loading...
Cat. No.: HY-19253A
CAS No.: 167006-13-5
KRH-594 is an orally active angiotensin AT1 receptor antagonist. KRH-594 ameliorates the progression of diabetic nephropathy and hyperlipidaemia. KRH-594 inhibits cardiac hypertrophy .
loading...
    loading...
Cat. No.: HY-180322
CAS No.: 1592640-75-9
Target:  

Glutaminase

TG2-IN-3h (Compound 3h) is a transglutaminase (TG2) inhibitor (hTG2: IC50 = 6nM). TG2-IN-3h inhibits endothelial cell migration and angiogenesis. TG2-IN-3h alleviates renal fibrosis in a mouse model of hypertensive nephropathy. TG2-IN-3h can be used in research on metabolic diseases such as hypertensive nephropathy and cardiovascular and cerebrovascular diseases such as pathological angiogenesis .
loading...
    loading...